Adenosine analogues and their use as pharmaceutical agents

Details Adenosine analogues and their use as pharmaceutical agents Adenosine analogues and their use as pharmaceutical agents

2007-09-04

2007-09-04

Berch, Mark L. (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S263400, C514S046000, C536S027300, C536S027620, C544S118000, C544S277000

Reexamination Certificate

active

10608689

ABSTRACT:
The present invention relates to compounds according to the general formula (I)wherein X is selected from the group consisting ofwherein n and p are independently 0, 1, 2, or 3, provided that n+p is a least 1;and unsubstituted and at least monosubstituted C1-C10-alkylene-Y, C2-C10-alkylene-Y, C3-C10-cycloalkylene-Y and C3-C10-cycloalkenylene-Y; andR1, A, B, Q, T, Y, E and W have the meanings given in the description.These compounds are useful for the manufacture of a medicament for the treatment of insulin resistance, type 2 diabetes, metabolic syndrome, lipid disorders or cardiovasular disease or for providing an anti-lipolytic effect.

REFERENCES:
patent: 4755594 (1988-07-01), Bridges et al.
patent: 5364862 (1994-11-01), Spada et al.
patent: 5561134 (1996-10-01), Spada et al.
patent: 5652366 (1997-07-01), Spada et al.
patent: 5736554 (1998-04-01), Spada et al.
patent: 6376472 (2002-04-01), Myers et al.
patent: 6407076 (2002-06-01), Box et al.
patent: 6455510 (2002-09-01), Charles et al.
patent: 6559313 (2003-05-01), Myers et al.
patent: 2006/0009417 (2006-01-01), Elzein et al.
patent: 2006/0052330 (2006-03-01), Zablocki et al.
patent: 0181129 (1986-05-01), None
patent: 1101108 (1968-01-01), None
patent: WO88/03147 (1988-05-01), None
patent: WO95/07921 (1995-03-01), None
patent: WO97/33591 (1997-09-01), None
patent: WO99/24449 (1999-05-01), None
patent: WO99/24450 (1999-05-01), None
Saltiel, A.R., et. al., The Molecular and Physiological Basis of Insulin Resistance: Emerging Implications for Metabolic and Cardiovascular Diseases, The Journal of Clinical Investigation (2000) vol. 106, No. 2 pp. 163-164.

Affiliated with

Also associated with

Rating

Adenosine analogues and their use as pharmaceutical agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Adenosine analogues and their use as pharmaceutical agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adenosine analogues and their use as pharmaceutical agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3722435